SHANNON LAMBERT: Open Payments
NPI 1548406952 · UPLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,233 in 56 payments from 15 companies in 2025. Trend: 2023 $538 · 2024 $1,123 · 2025 $1,233
Food & beverage: $1,233
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $191 |
| PFIZER INC. | 10 | $190 |
| Arcutis Biotherapeutics, Inc. | 7 | $170 |
| GENZYME CORPORATION | 5 | $163 |
| UCB, Inc. | 4 | $146 |
| Galderma Laboratories, L.P. | 2 | $60 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Regeneron Healthcare Solutions, Inc. | 1 | $42 |
| Janssen Biotech, Inc. | 3 | $41 |
Products named: DUPIXENT, Zoryve, Bimzelx, CIBINQO, SKYRIZI, RINVOQ, Winlevi, LITFULO.
Industry payments across CA — which companies pay providers there.
